Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne (TECH) trades at $72.31, down 0.17% on the day, with a neutral technical signal and mixed earnings history. The stock is near the consensus price target of $71.86, with a pending acquisition by Merck KGaA at $73.00 per share. Recent Q4 2026 revenue beat estimates, but net income margin compression from 25.09% in 2023 to 14.96% in 2026 highlights profitability challenges. Operating cash flow remains stable around $290M, supporting dividend payments.
The outlook is balanced, with upside capped by the acquisition offer but supported by solid cash flow and analyst hold ratings. Risks include shareholder litigation and integration uncertainties post-acquisition. Earnings growth in diagnostics and spatial biology segments is a key catalyst, though high P/E of 62.33 suggests elevated expectations.
Read full analysis

Key Stats

  • Market Cap
    $11.34B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.36B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.39
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

Coinbase CEO Brian Armstrong expressed confidence that the Clarity Act, a U.S. federal bill to regulate digital assets, is likely to pass the Senate with broad support from crypto firms and banks. The legislation aims to clarify oversight between the...

Market News
4 hours ago
CNBC
Bullish
news icon
Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

HIVE Digital appoints Mark Volk to lead global AI revenue growth and surpasses $1M daily revenue in AI and Bitcoin mining.

HIVE Digital Technologies has appointed Mark Volk as Senior Vice President, Revenue at its subsidiary BUZZ HPC to drive global AI infrastructure sales. Volk brings extensive experience from HPE, IBM, and other tech firms to scale BUZZ's GPU-powered A...

Market News
5 hours ago
Newsfile Corp
Bullish
news icon
HIVE Digital appoints Mark Volk to lead global AI revenue growth and surpasses $1M daily revenue in AI and Bitcoin mining.

ZeroRisk raises $10M to expand global cybersecurity services for payment providers.

ZeroRisk, an Irish cybersecurity firm specializing in risk management for payment providers, secured $10 million in a Series A funding round led by MiddleGame Ventures and Elkstone. Founded in 2023, ZeroRisk offers a platform that helps banks and pay...

Market News
5 hours ago
PRNewsWire
Bullish
news icon
ZeroRisk raises $10M to expand global cybersecurity services for payment providers.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.34B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $72.48
  • 52W Low
    $43.31
  • Typical Hold Time
    -
  • Enterprise Value
    $11.36B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.39
52W Low: $43.31
15 May 2026
52W High: $72.48
19 Aug 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.48, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!